|
Volumn 5, Issue , 2010, Pages 367-373
|
Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
SCOPOLAMINE DERIVATIVE;
TIOTROPIUM BROMIDE;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONVALESCENCE;
DAILY LIFE ACTIVITY;
FEMALE;
GERMANY;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
NEBULIZER;
PATHOPHYSIOLOGY;
PATIENT SATISFACTION;
PROSPECTIVE STUDY;
QUESTIONNAIRE;
TIME;
TREATMENT OUTCOME;
ACTIVITIES OF DAILY LIVING;
ADMINISTRATION, INHALATION;
AGED;
BRONCHODILATOR AGENTS;
CHOLINERGIC ANTAGONISTS;
FEMALE;
GERMANY;
HUMANS;
MALE;
MIDDLE AGED;
NEBULIZERS AND VAPORIZERS;
PATIENT SATISFACTION;
PROSPECTIVE STUDIES;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
QUESTIONNAIRES;
RECOVERY OF FUNCTION;
SCOPOLAMINE DERIVATIVES;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 79952198106
PISSN: None
EISSN: 11782005
Source Type: Journal
DOI: 10.2147/copd.s14082 Document Type: Article |
Times cited : (15)
|
References (0)
|